 SOUTH SAN FRANCISCO, Calif.--BUSINESS WIRE--Twist Bioscience Corporation NASDAQ: TWST, a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that Jim Thorburn, CFO of Twist Bioscience, and Patrick Finn, Ph.D., CCO of Twist Bioscience, will host a fireside chat and one-on-one meetings at the UBS Genomics 2.0 and Medtech Innovations Summit on Tuesday, August 9th, at 2:00 p.m. Pacific Time in Dana Point, Californi 